TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
INCY

Incyte Corporation

Healthcare · Biotechnology

127.60$ +2.3% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Incyte Corporation (INCY): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/27/2026.

Next report 10/27/2026
Last report 07/28/2026
Earnings surprise by quarter (%)
Q3 23 · 2.8 % 23 Q4 23 · -7.8 % 23 Q1 24 · -22.9 % 24 Q2 24 · -264.0 % 24 Q3 24 · -1.8 % 24 Q4 24 · -7.7 % 24 Q1 25 · 12.6 % 25 Q2 25 · 6.8 % 25 Q3 25 · 37.8 % 25 Q4 25 · -6.3 % 25 Q1 26 · 35.1 % 26 Q2 26 · 59.1 % 26

EPS estimate beaten

Full history 69 of 124 quarters (56%)
Last 16 quarters 8 of 16 quarters (50%)

Earnings Call Transcripts

Search all transcripts →

  • 04/28/2026 Earnings Call Q1 2026 Open →
  • 02/10/2026 Earnings Call Q4 2025 Open →
  • 10/28/2025 Earnings Call Q3 2025 Open →
  • 07/29/2025 Earnings Call Q2 2025 Open →
  • 04/29/2025 Earnings Call Q1 2025 Open →
  • 02/10/2025 Earnings Call Q4 2024 Open →
  • 10/29/2024 Earnings Call Q3 2024 Open →
  • 07/30/2024 Earnings Call Q2 2024 Open →
  • 04/30/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 08/31/2026 INCYTE CORP (INCY): Other Events · sec.gov Open ↗
  • 07/28/2026 INCYTE CORP (INCY): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/06/2026 INCYTE CORP (INCY): Other Events; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?